Singh J, Handelsman D J
Andrology Unit, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
J Androl. 1996 Jul-Aug;17(4):382-93.
In order to clarify the mechanism of synergism between follicle-stimulatory hormone(FSH) and testosterone (T) in the hormonal regulation of spermatogenesis, we studied the effects of recombinant human FSH (rhFSH) on the induction of spermatogenesis by testosterone in congenitally gonadotropin-deficient hpg mice. Weanling (day 21) homozygous hpg mice were administered daily subcutaneous injections of 1, 5, or 10 IU of rhFSH alone or in combination with a subdermal testosterone implant until day 70 of age. Spermatogenesis was quantitated by stereological estimation of germ cell populations and Sertoli cells as well as measurement of diameter of seminiferous tubules and their lumina in perfusion-fixed testes and by counting homogenization-resistant condensed testicular spermatids. Recombinant human FSH alone increased the absolute numbers of spermatogonia (x3.5-fold) and spermatocytes (x3-fold) compared with untreated hpg mice but did not significantly increase Sertoli cell numbers or form any condensed spermatids or tubular lumen. Relative to Sertoli cell numbers, rhFSH alone increased populations of spermatogonia (x2-fold) and spermatocytes (x2-fold). The addition of T to rhFSH further increased the absolute numbers of spermatogonia (x5-fold) and spermatocytes (x3.5-fold) compared with untreated hpg mice as well as increasing tubular diameter and forming tubular lumina. In addition administration of T allowed the completion of spermatogenesis in the presence of intratesticular T levels that were approximately 2% of non-hpg controls. All effects of the FSH + T combination were however no greater than the effects of the equivalent dose of T alone. The present study therefore indicates that rhFSH alone increases proliferation of premeiotic spermatogenic cells but has no effect on the completion of spermiogenesis or on Sertoli cell maturation. Furthermore we were unable to identify any additive effects of FSH with T in the hormonal regulation of spermatogenesis in the hpg mouse. This suggests that FSH or T both may stimulate initial spermatogenic development, but only T can complete spermiogenesis.
为了阐明促卵泡激素(FSH)和睾酮(T)在精子发生激素调节中的协同作用机制,我们研究了重组人FSH(rhFSH)对先天性促性腺激素缺乏的hpg小鼠中睾酮诱导精子发生的影响。将断奶(第21天)的纯合hpg小鼠每天皮下注射1、5或10 IU的rhFSH,单独注射或与皮下睾酮植入物联合注射,直至70日龄。通过对生殖细胞群体和支持细胞进行体视学估计,以及测量灌注固定睾丸中曲细精管及其管腔的直径,并通过计数抗匀浆浓缩睾丸精子细胞,对精子发生进行定量分析。与未处理的hpg小鼠相比,单独使用重组人FSH可使精原细胞的绝对数量增加(3.5倍),使精母细胞的绝对数量增加(3倍),但未显著增加支持细胞数量,也未形成任何浓缩精子细胞或管腔。相对于支持细胞数量,单独使用rhFSH可使精原细胞群体增加(2倍),使精母细胞群体增加(2倍)。与未处理的hpg小鼠相比,在rhFSH中添加T可进一步增加精原细胞的绝对数量(5倍)和精母细胞的绝对数量(3.5倍),同时增加管腔直径并形成管腔。此外,给予T可在睾丸内T水平约为非hpg对照的2%的情况下完成精子发生。然而,FSH + T组合的所有作用均不大于等效剂量单独T的作用。因此,本研究表明,单独使用rhFSH可增加减数分裂前生精细胞的增殖,但对精子形成的完成或支持细胞的成熟没有影响。此外,我们无法确定FSH与T在hpg小鼠精子发生激素调节中的任何相加作用。这表明FSH或T均可刺激初始生精发育,但只有T能完成精子形成。